|
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Background:
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. CT-guided radiofrequency ablation may be effective treatment for lung cancer. This is a Phase II trial to study the effectiveness of radiofrequency ablation in treating patients who have refractory or advanced lung cancer.
Objectives:
 | Determine the safety and toxicity of radiofrequency ablation in patients with refractory or advanced pulmonary malignancies. | | Determine the efficacy of this treatment, in terms of local control, in these patients. | | Determine whether CT scan is a reasonable imaging assessment tool for treatment delivery and follow-up in these patients. |
Location/Contact Information:
California
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States;
Recruiting
Robert D. Suh, MD 310-794-2168
Study chairs or principal investigators
Robert D. Suh, MD, Study Chair
Jonsson Comprehensive Cancer Center
|
 |
|
